PARIS, June 2, 2026 /PRNewswire/ — China-France cultural exchange has been enriched with new vitality as two events were held in Paris on May 29. Both events were supported by the Information Office of the People’s Government of Shaanxi Province, China. One was hosted by the Information Office of the People’s Government of Xi’an Municipality, and the other was co-hosted by the Information Offices of Xi’an and the People’s Governments of Tongchuan City.
The events drew more than 100 guests from various sectors, including Mehrdad Shabahang, Head of UNESCO’s Silk Roads Programme, and Marie-Pierre Boucher Hollier, special adviser to the UN World Tourism Organization.
Event Scene
At the “Silk Road Civilization: Tang Poetry Culture and Shaanxi Intangible Cultural Heritage Day” event held at UNESCO Headquarters that morning, representative works of Shaanxi intangible cultural heritage, including dough figurines, tie-dyeing, paper-cutting, and Yaozhou porcelain, were displayed, offering guests an immersive experience of the craftsmanship and cultural traditions of Shaanxi. During the event, Chinese and French guests engaged in discussions on “The Contemporary Value of Tang Poetry and Mutual Learning Between Chinese and French Cultures,” exchanging their views on the natural imagery and humanistic spirit reflected in Tang poetry, as well as the French literary and artistic treatment of nature and humanity. They also recited renowned Tang poems in both French and Chinese, filling the air with verse that transcended language barriers.
That afternoon saw the Shaanxi Culture Day and “Eternal Dialogue: Cultural Heritage Protection and Urban Renewal” Exhibition. Divided into three sections, “Deep Roots of Civilization,” “Safeguarding Cultural Heritage,” and “Renewal and Rebirth,” the exhibition highlighted preservation cases like Xi’an City Wall, Yaozhou Kiln and Yan’an revolutionary sites, and folk art innovations such as Huxian County peasant paintings and Fengxiang clay sculpture. In addition, the exhibition featured images documenting China-France cooperation since 2014 on restoration projects including Gongshutang painted murals, Maoling stone carvings, and Notre-Dame de Paris, highlighting the joint efforts of both countries to protect our shared cultural heritage.
Outside the venue, Paris residents and visitors were drawn to the vivid colors and rich imagery of farmers’ paintings from Huxian County. Many picked up brushes to add color to the artworks, resulting in a jointly created “China-France edition” blending elements of both cities’ farmers painting traditions. One Paris resident said, “The colors are captivating. Here in Paris, I’ve become part of an artwork from Xi’an.”
A new centrally located clinic designed to enhance patient comfort and accessibility
SINGAPORE – Media OutReach Newswire – 2 June 2026 – TruGlow Medical Aesthetics announces its upcoming relocation to a new clinic space at The Heeren, one of Orchard Road’s most recognisable lifestyle destinations. The new clinic, located at 260 Orchard Road, #04-12 The Heeren, Singapore 238855, is scheduled to open on 02 June 2026. Situated along Orchard Road and within proximity to MRT stations and bus stops, the new location offers greater convenience for both existing and new patients.
TruGlow Medical Aesthetics @ Heeren #04-12
A Thoughtful Step Forward for the Clinic
The new clinic space has been designed with patient comfort and discretion in mind, featuring a larger layout, enhanced privacy, upgraded consultation areas, and improved treatment room facilities. With this move, TruGlow aims to continue delivering care in a setting that reflects its emphasis on discretion, consistency, and professional standards, while supporting the clinic’s next phase of growth.
TruGlow aims to continue delivering care in a setting that aligns with its emphasis on discretion, consistency, and professional standards, while preparing the clinic for its next phase of growth.
A Clinic Environment Designed Around Patient Care
The new space has been planned to support a smoother experience from consultation to follow-up care, with upgraded treatment rooms and consultation spaces. This enables the clinical team to deliver care more efficiently and comfortably, without altering TruGlow’s established care philosophy.
While the physical space has evolved, the clinic’s commitment to careful assessment, appropriate recommendations, and evidence-based treatments remains unchanged.
Clinical Expertise Across Face, Eyes, and Body Concerns
TruGlow Medical Aesthetics is known for its experience in managing a range of commonly requested aesthetic concerns. The clinic is frequently consulted for undereye and eye bag treatments, where factors such as puffiness, volume changes, and skin quality are assessed holistically to guide suitable non-surgical approaches.
In addition, TruGlow provides care for back acne management, developing treatment plans that focus on skin clarity, comfort, and gradual improvement over time. These areas reflect the clinic’s emphasis on addressing both facial and body concerns through individualised assessment.
To support its clinical recommendations, TruGlow offers a selection of non-invasive aesthetic technologies. These include Ultraformer MPT, which uses micro- and macro-focused ultrasound to address skin laxity and contour definition at different depths.
The clinic also provides Oligio, a monopolar radiofrequency treatment designed to support collagen remodelling and improve skin firmness, including areas that require more delicate handling such as around the eyes. As aesthetic technologies continue to evolve worldwide, TruGlow remains attentive to developments that may further enhance patient care in the future.
Looking Ahead at The Heeren
With its upcoming opening at The Heeren, TruGlow Medical Aesthetics looks forward to welcoming patients into a refreshed clinical environment while continuing to deliver the same medically guided, patient-centred care it is known for.
New address:
260 Orchard Road, #04-12 The Heeren Singapore 238855 Opening: 02 June 2026
The issuer is solely responsible for the content of this announcement.
TruGlow Medical Aesthetics
At TruGlow Medical Aesthetics, we celebrate the transformative power of authenticity and the radiant glow that emanates from within. Our name, a harmonious blend of “True” and “Glow,” reflects our unwavering commitment to enhancing your genuine beauty and fostering a luminous, healthy appearance.
A picture of BOL Director General Phanousack Kenevongphachanh giving a press release to address EU sanctioned on JDB. (Photo by Bank of Laos)
The Bank of Laos (BOL) has publicly addressed European Union (EU) sanctions imposed on the Joint Development Bank (JDB), which threatened the bank’s international operations.
The EU announced on 14 May that it would restrict JDB as part of its latest sanctions package targeting Russia. The measures bar EU-based banks from conducting financial transactions with JDB and block the bank’s access to EU clearing and settlement systems.
At a press conference on 30 May, BOL Director General Phanousack Kenevongphachanh said the central bank is closely monitoring the situation and has taken steps to mitigate issues arising from the sanctions. He emphasized that the restrictions apply only within the EU and do not affect transactions with banks in non-EU countries.
To address the issue, BOL has established a dedicated team to coordinate with the EU while guiding JDB in preparing a corrective action plan in line with international standards.
BOL is also working with international and EU legal and financial experts to review regulatory compliance and strengthen oversight mechanisms.
Phanousack said the Lao banking system remains stable and that the sanctions do not affect other financial institutions operating in Laos.
He added that customers can continue using JDB’s domestic banking services, including deposits, withdrawals, payments, transfers and loans as normal. For transactions involving EU member states, customers were advised to use international transfer services provided by other domestic banks.
He also confirmed that JDB remains compliant with regulatory capital and liquidity requirements.
MANILA, PHILIPPINES – Media OutReach Newswire – 2 June 2026 –Vinpearl Joint Stock Company has signed Memorandums of Understanding (MoUs) with CAITO and Klook, partners with extensive networks and influence in the travel and digital tourism sectors in the Philippines and across the region. The agreements aim to enhance Vinpearl’s brand presence while promoting premium resort, golf, MICE and travel experience products in Nha Trang, Phu Quoc, and Da Nang to Filipino travelers.
The MoUs were signed during the Vietnam–Philippines Business Forum, held as part of the official visit by Party General Secretary and President Tô Lâm to the Republic of the Philippines.
The partnership with CAITO aims to enhance Vinpearl’s brand awareness within the Philippines’ travel trade community while creating additional opportunities to develop hospitality, entertainment and MICE offerings in Nha Trang, Phu Quoc and Da Nang. CAITO is currently one of the Philippines’ leading tourism organizations, with an extensive network of travel businesses across the region.
With Klook, one of Asia’s leading travel experience platforms, Vinpearl and VinWonders aim to expand their strategic collaboration across distribution, communications and tourism promotion in key international markets, particularly the Philippines and broader Southeast Asia. The partnership is expected to expand the presence of the Vinpearl–VinWonders ecosystem in major international markets, while further elevating Vietnam’s tourism image across global travel and digital media platforms.
Ms. Ngo Thi Huong, Chief Executive Officer of Vinpearl, shared: “Through these agreements in the Philippines, alongside a series of partnership initiatives in Thailand and Singapore, Vinpearl aims to drive high-quality inbound tourism to Vietnam, strengthen connectivity among ASEAN markets, and enhance the competitiveness of Vietnam’s tourism industry. With an integrated ecosystem spanning hospitality, entertainment, golf, and commercial services, Vinpearl remains committed to pioneering world-class experiences that contribute to positioning Vietnam as a leading destination in the Asia-Pacific region.”
Mr. Michelle Ho, Chief Executive Officer of Klook Philippines, said: “Vinpearl currently operates one of the region’s most distinctive tourism and entertainment ecosystems, with strong capabilities in integrating hospitality, theme parks and premium leisure experiences. We believe our partnership with Vinpearl will further enhance the appeal of Nha Trang, Phu Quoc and Da Nang among travelers across the region.”
Previously, during its business engagements in Thailand and Singapore, Vinpearl also entered into MoUs with Agoda, AirAsia MOVE, BeMyGuest and GlobalTix to expand international distribution channels for its hospitality, resort and travel experience offerings.
Together with the agreements established in the Philippines, this series of partnerships with leading regional players across aviation, travel trade, digital tourism, and travel distribution reflects Vinpearl’s ongoing efforts to build a comprehensive international market development network across Southeast Asia.
Beyond expanding its partner ecosystem, these collaborations provide a foundation for Vinpearl to strengthen its presence in key markets, engage more effectively with international travelers, and enhance the competitiveness of Vietnam’s tourism industry within the region.
The issuer is solely responsible for the content of this announcement.
About CAITO
CAITO (Calabarzon Alliance of Independent Tour Operators, Inc.) ONE CALABARZON is an association of independent travel businesses and tourism partners in the Philippines, established in 2020. With a rapidly expanding member network and close collaboration with the Philippines Department of Tourism (DOT), CAITO has become one of the country’s most dynamic tourism organizations, playing an active role in tourism promotion, business connectivity and international collaboration, particularly in the areas of MICE and B2B. The organization is anchored in a vision to promote Philippine destinations, tourism products, cultural heritage, cuisine, and services while strengthening the country’s tourism identity through collaboration, shared promotion, and collective growth.
About Klook Klook is one of the leading travel experience platforms in the Asia-Pacific region, offering attractions, tours, transportation, accommodation, and travel services on a global scale. To date, Klook has recorded more than 65 million bookings across over 200 markets, supporting more than 40 payment methods alongside e-ticketing services and 24/7 customer support.
The platform currently operates a community of more than 30,000 content creators across 88 markets, helping promote tourism and inspire exploration for millions of travelers worldwide.
About Vinpearl
Vinpearl is Vietnam’s leading tourism, hospitality and entertainment brand, currently operating 60 properties across 20 provinces and cities nationwide. Its ecosystem includes a network of five-star hotels and resorts with more than 17,500 rooms; 16 VinWonders theme parks offering a wide range of attractions for all audiences; six world-class golf courses; and three international-standard convention centers and theaters under the VinPalace brand. The ecosystem also features two semi-wildlife conservation and care parks, an equestrian academy, and million-dollar live-action shows in Nha Trang and Phu Quoc, attracting millions of visitors each year.
Continued global expansion brings the Content Innovation Cloud to the Asia-Pacific region, enabling organizations to scale AI‑driven operations in compliance with local data residency requirements
SYDNEY, June 2, 2026 /PRNewswire/ — As AI adoption accelerates, data sovereignty has become a deciding factor for regulated industries across Asia-Pacific region. This is why Hyland, a global leader in enterprise content management (ECM) and the pioneer of the content-powered agentic enterprise, today announced the continued expansion of its AI‑native Content Innovation Cloud™ across the Asia-Pacific region in collaboration with Amazon Web Services (AWS). Building on their strategic collaboration agreement (SCA), this expansion brings Hyland to the AWS Asia Pacific (Sydney) Region, enabling highly regulated, content-rich industries such as healthcare, financial services, insurance, education, and government, to unlock governed, AI‑ready content and scale agent‑driven operations with greater performance and lower latency.
Hyland_Logo_New
“With demand for AI-driven enterprise solutions accelerating globally, organizations across the Asia-Pacific region want to take advantage of AI but are mindful of data sovereignty and deploying advanced content and AI capabilities within their own regional infrastructure,” said Tim McIntire, chief technology officer at Hyland. “By extending the Content Innovation Cloud into Australia, Hyland is removing that barrier, empowering our customers to move forward with confidence as they modernize core operations and adopt the agentic enterprise.”
“This expansion of Hyland’s partnership with AWS significantly strengthens the foundation for delivering AI‑native innovation across Australia and the Asia-Pacific region” said Mark Grimes, managing director at Blumark. “With local access to the Content Innovation Cloud, organizations can realize the true benefits of the content‑powered agentic enterprise, and we look forward to working with Hyland to help our customers realize their full potential.”
“The next phase of enterprise AI will be defined by how effectively organizations can connect intelligence to real business processes,” said Carol Potts, General Manager, ISV, at AWS. “By expanding our partnership with Hyland in Australia, New Zealand and across the Asia-Pacific region, we are helping customers unlock the full value of their content-powered agentic automation and build a trusted foundation for AI innovation on AWS.”
Empowering the Agentic Enterprise Across the Asia-Pacific Region
Hyland is advancing its leadership as the pioneer of the content‑powered agentic enterprise by delivering the critical foundation organizations need to scale AI beyond experimentation. This includes the company’s latest wave of innovations, including the Enterprise Context Engine, Agent Lifecycle Management, Enterprise Agent Mesh, and headless capabilities for the Content Innovation Cloud that bring together governed content, industry specific context, and agent orchestration into a unified platform. Built on decades of expertise in highly regulated industries, Hyland uniquely enables enterprises to connect AI to real business processes with the trust, control, and domain intelligence required to drive meaningful, scalable outcomes in the age of agentic automation.
By bringing the Content Innovation Cloud closer to where customers operate, Hyland and AWS are enabling their customers across the region to deliver faster, more reliable digital experiences, unlock new revenue opportunities, and scale AI‑driven innovation without compromising governance or compliance.
Hyland will also be bringing its annual user conference, CommunityLIVE, to Melbourne, Australia on 25 August 2026.
For more information on Hyland’s platform and solutions, please visit Hyland.com.
About Hyland Hyland is the pioneer of the Content Innovation Cloud™ , delivering ubiquitous enterprise intelligence to organizations with solutions that unlock actionable insights and drive automation. Trusted by thousands of organizations worldwide, including many of the Fortune 100, Hyland’s solutions create the foundation for a connected, agentic enterprise, where teams harness the power of AI to redefine how they operate and engage with those they serve. For additional information on Hyland’s platform and services, please visit Hyland.com.
In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026, issued 01-Jun-2026 by Ranok Therapeutics over PR Newswire, we are advised by the company that the first sub-headline, the 3rd paragraph, and the contact details have been updated. The complete, corrected release follows:
Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026
Clinically Meaningful Overall Antitumor Activity, with ORR of 42.6% and DCR of 95.7% across all evaluated dose levels in heavily pretreated patients.
Enhanced Clinical Activity at the Recommended Phase 2 Dose (RP2D), with ORR of 50% in patients who were Taxane-Naïve.
Differentiated safety profile; RNK08954 was well tolerated, with 1200 mg once daily established as the RP2D.
WALTHAM, Mass. and HANGZHOU, China, June 2, 2026 /PRNewswire/ — Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced positive interim Phase 1 clinical data for RNK08954, an investigational oral, selective KRAS G12D inhibitor. The results were featured in an Oral Presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The multicenter Phase 1 study (NCT06667544) evaluated RNK08954 in heavily pre-treated patients with KRAS G12D-mutated solid tumors in China.
Based on comprehensive assessment of safety, tolerability, pharmacokinetics, and anti-tumor activity, a dose of 1200 mg once daily (QD) was selected as the Recommended Phase 2 Dose (RP2D).
In the cohort of patients (N=47) with metastatic non-small cell lung cancer (NSCLC), RNK08954 demonstrated enhanced anti-tumor activity. In the overall evaluable NSCLC population across all tested doses (400–1200 mg, QD), the Objective Response Rate (ORR) was 42.6% (95% confidence interval (CI), 28.3%–57.8%), alongside a Disease Control Rate (DCR) of 95.7% (95% CI, 85.5%–99.5%).
Clinical activity was further enhanced at the RP2D of 1200 mg QD. Patients with only one prior line of therapy achieved an ORR of 45.0% (95% CI, 23.1%–68.5%), and DCR of 95.0% (95% CI, 75.1%–99.9%). Notably, patients who were taxane-naïve achieved the highest response rate in the study, with ORR of 50.0% (95% CI, 26.0%–74.0%) and DCR of 94.4% (95% CI, 72.7%–99.9%), demonstrating the potent antitumor activity of RNK08954. Longitudinal follow-up demonstrated durable clinical benefit. Progression-free survival (PFS) data for the optimized 1200 mg QD cohort remain immature and continue to mature. In the pooled lower-dose cohorts (400–1000 mg QD), RNK08954 achieved a median PFS of 7.6 months (95% CI, 2.8–NR). Robust molecular responses were evidenced by circulating tumor DNA (ctDNA) kinetics, corroborating the radiologic responses. Among the evaluable patients, 83.3% achieved a critical biological threshold of ≥50% variant allele frequency (VAF) clearance of the mutant KRAS G12D clone. Crucially, 44.4% of patients achieved complete molecular clearance of the driver mutation, providing strong biological validation of RNK08954 potent target engagement and mechanism of action.
Professor Zhengbo Song, MD, PhD, Lead Investigator, Zhejiang Cancer Hospital commented “These interim data are highly encouraging for patients with advanced KRAS G12D-mutated NSCLC who currently face limited treatment options. Achieving a 50.0% response rate specifically in taxane-naïve patients at the 1200 mg RP2D provides a strong scientific rationale for moving RNK08954 into earlier lines of therapy, before the introduction of traditional chemotherapy. Combined with a favorable, manageable safety profile, RNK08954 demonstrates the potential to significantly shift how we sequence treatments for these patients.”
“The clinical activity and tolerability observed at the 1200 mg QD dose level confirm that RNK08954 is a highly competitive agent in the KRAS G12D landscape. The robust responses in taxane-naïve patients strongly support our strategy to explore RNK08954 in earlier treatment lines.” said Iman El-Hariry, MD, PhD, Chief Medical Officer, Ranok Therapeutics. “Our immediate focus is on swift clinical execution to fully characterize this monotherapy profile in broader NSCLC populations while systematically exploring RNK08954’s potential in rational combination regimens.”
“The clinical results demonstrated by RNK08954 at ASCO represent a significant corporate milestone for Ranok Therapeutics, establishing a well-tolerated, active oral profile at the RP2D.” commented Weiwen Ying, PhD, Chief Executive Officer, Ranok Therapeutics. “This strong data package provides us with excellent strategic flexibility as we evaluate corporate development opportunities to accelerate our clinical programs. These results also offer a powerful validation of our internal discovery platform, giving us high confidence as we advance our broader multi-asset KRAS franchise spanning G12D, G12C, and beyond.”
About RNK08954
RNK08954 is a highly selective, oral KRAS G12D inhibitor with unique pharmacokinetic properties designed for deep, sustained target inhibition. It is currently being investigated as monotherapy and in combination with chemotherapy and/or other targeted agents in NSCLC, PDAC, and additional solid tumor indications.
About Ranok Therapeutics
Ranok Therapeutics is a clinical-stage biopharmaceutical company developing next-generation targeted oncology therapies. Its pipeline includes multiple programs against high-value oncogenic drivers, with a lead program in KRAS G12D (RNK08954).
Licensed independent lender offers standalone premium financing solution, providing institutional-grade funding without AUM requirements or asset pledges
HONG KONG, June 2, 2026 /PRNewswire/ — Yuvarra, a licensed independent lender, today announces its launch, bringing a new model for life insurance premium financing to the wealth market. In cooperation with LifeDirect and drawing on expertise from Apeiron Group, Yuvarra offers wealth managers, financial advisers and their high-net-worth clients a way to fund life insurance independently.
Premium finance has historically been delivered through private banking channels and broader wealth management relationships. Today, a growing share of HNWI relationships sit with independent advisers, multi-family offices and specialist wealth managers, reshaping how premium finance solutions are delivered. By allowing premium financing to sit alongside any advisory relationship, Yuvarra makes it possible for more advisers to offer more to their clients without introducing a new institution.
Yuvarra expands the range of premium finance solutions available to advisers and their clients. Loans are secured against the life insurance policy itself, not the client’s investment portfolio or other assets. Without any AUM requirements or account openings, financing exists independently of the client’s existing banking and investment arrangements.
Larry Ikard, CEO, Yuvarra comments: “Wealth managers and advisers shouldn’t have to walk their clients into a bank to buy a life insurance policy. Yuvarra decouples those two things. We are the lender, we have the capital, and we focus on the policy. Nothing else needs to change for the client or the adviser.”
The launch is in partnership with LifeDirect, part of AFCO Credit Corporation, a subsidiary of Truist Bank and a leader in premium finance. The bank’s institutional balance sheet provides the scale and stability for Yuvarra to operate reliably and at pace. Yuvarra’s independent governance structure supports a focused and streamlined underwriting process designed specifically for premium finance. The platform is built to provide advisers and clients with a transparent and efficient experience. Applications are reviewed and approved in a matter of weeks and wealth managers and advisers have full visibility at every stage, from submission through to funding.
Rene Stuifzand, Chief Business Development Officer, LifeDirect says: “This partnership positions us to better serve the growing global demand for premium finance while further diversifying our loan portfolio. It reflects our commitment to the international markets and delivering a more connected premium finance platform for advisers and clients in key regions around the world.”
For insurance carriers, Yuvarra’s model translates directly into more policies sold and more policies remaining in force. Because lending is secured against the policy alone and not tied to investment portfolio performance, the risk of a loan being called, and a policy surrendered as a result, is eliminated. By removing certain asset and relationship requirements traditionally associated with premium financing, Yuvarra expands the pool of clients for whom a funded policy may be viable.
Yuvarra, a company incorporated in the Cayman Islands with operations in Hong Kong, is now open for business. For more information visit: https://yuvarra.com/
Notes to editors
About Yuvarra Yuvarra is an independent lender delivering institutional-grade premium financing for high-net-worth individuals, wealth managers and financial advisers across Asia. In partnership with Truist Bank and drawing on expertise from Apeiron Group, Yuvarra decouples life insurance premium financing from traditional banking relationships, offering a faster, more transparent and conflict-free funding model secured against the policy alone.
About LifeDirect LifeDirect is a leading life insurance premium finance company providing highly personalized services to create a unique customer experience. Based in Lake Forest, IL, LifeDirect is part of AFCO Credit Corporation, a subsidiary of AFCO Holdings LLC and Truist Bank, and a leader in premium finance. LifeDirect has redefined the industry with its strong focus on technology-driven solutions and unparalleled processing efficiency. Learn more: LifeDirect.com
About Apeiron Group Apeiron Group is the leading global marketplace for end-to-end insurance for high-net-worth individuals.
Dragos expands to protect xOT including OT systems and the billions of connected devices that have reshaped how critical infrastructure operates
HANOVER, Md., June 2, 2026 /PRNewswire/ — Dragos, the global leader in cybersecurity for operational technology (OT) environments, today announced it has acquired Phosphorus, extending the Dragos Platform to protect the billions of connected devices embedded across critical infrastructure and other operational networks.
Operational environments have outgrown traditional OT boundaries. Power grids, pipelines, manufacturing facilities, and data centers now depend on an increasingly diverse mix of connected devices and digital systems. Traditional and non-traditional assets alike are woven throughout their operational environments. This expanded environment — OT systems and the billions of connected devices that have reshaped how critical infrastructure operates — is the Extended Operational Technology environment, or xOT. Adversaries are already operating across it. Defenders need a broader scope of visibility, intelligence, and control to defend it.
Dragos’s acquisition of Phosphorus reflects a deliberate strategy to protect the full operational environment as it exists and operates today. Dragos offers the industry’s most comprehensive OT cybersecurity platform. Adding Phosphorus extends Dragos capabilities to secure connected devices across the full xOT environment, delivering deeper device visibility, automated remediation, and continuous risk reduction.
“The connected devices you find everywhere in critical infrastructure are largely invisible to the cybersecurity programs that protect operational environments,” said Robert M. Lee, CEO and Co-Founder of Dragos. “With Phosphorus, we close that gap and secure xOT, the full environment that matters.”
“We built Phosphorus to solve the connected device problem — the unmanaged devices, the default credentials, the firmware no one was updating. Together with Dragos, we can solve it with a depth and scale that wasn’t possible before. That’s what the next generation of OT cybersecurity looks like,” said Sonu Shankar, President and COO of Phosphorus.
Phosphorus offers the industry’s most comprehensive discovery and remediation platform for connected devices, which integrates with customers’ existing infrastructure without requiring disruptive architectural changes. The platform actively discovers and provides deep visibility into devices across OT and enterprise environments, delivering detailed risk context and continuous situational awareness across the extended device landscape. Phosphorus automates remediation workflows, including password rotations, firmware updates, certificate management, and configuration hardening, while helping organizations address compliance and reduce risk at scale.
Dragos customers will gain expanded asset visibility and integrated device intelligence in the near term, with automated remediation workflows and a unified platform experience to follow. Phosphorus customers will continue to be fully supported, with expanded access to Dragos offerings as integration progresses. Sonu Shankar will continue to lead the Phosphorus business as a General Manager within Dragos, through a structured, phased integration.
With the addition of Phosphorus, Dragos estimates its total addressable market opportunity at more than $50 billion.* The acquisition builds on Dragos’s October 2024 acquisition of Network Perception, which added expanded OT network visibility, segmentation validation, and compliance to the Dragos platform. Where Network Perception maps and secures the network architecture, Phosphorus secures the devices running on it.
About Dragos
Dragos provides the most comprehensive OT cybersecurity technology to deliver on its global mission: to safeguard civilization. Purpose-built for the extended operational technology environment, or xOT, Dragos technology delivers asset visibility, continuous monitoring, OT vulnerability management, segmentation validation, device protection, and real-time threat detection, powered by the industry’s most experienced OT threat intelligence and incident response team. Dragos serves critical sectors including energy, manufacturing, water, transportation, and data centers. Privately held and headquartered in the Washington, DC area, Dragos operates globally across North America, EMEA, and APAC. Visit dragos.com.
*Dragos estimate based on third-party market research including MarketsandMarkets, “Operational Technology (OT) Security Market” (April 2025); Polaris Market Research, “Operational Technology (OT) Security Market” (2025).